Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Dimensional US High Profitability ETF (NY:DUHP)

38.04 +0.01 (+0.03%)
Streaming Delayed Price Updated: 11:28 AM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Dimensional US High Profitability ETF

< Previous 1 2 3 4 Next >
News headline image
CSX Stock Slips After Train Derailment, Chemical Leak In Rural Kentucky ↗
Associated Press reported, citing CSX, that no injuries were reported in the incident. 
Via Stocktwits
News headline image
Verisk Terminates $2.35 Billion AccuLynx Acquisition Amid FTC Deadline Delay ↗
Verisk Analytics said it has cancelled the AccuLynx acquisition after the Federal Trade Commission failed to complete its review by the Dec. 26, 2025, deadline. 
Via Stocktwits
News headline image
Why Analysts See Nvidia’s Groq Licensing Deal As A Clear Win For AI Leadership ↗
Despite the reported $20 billion price tag, brokerages believe the deal is small relative to Nvidia's scale and long-term earnings power. 
Via Stocktwits
Topics Artificial Intelligence
Pentagon Blames Lockheed Martin For F-35’s Lack Of Availability ↗
Via Stocktwits
News headline image
Lam Research Stock Saw A Price Target Hike From B. Riley – What’s The Driving Factor? ↗
B. Riley raised its price target on Lam Research to $195 from $180. 
Via Stocktwits
Topics Artificial Intelligence
US Senators Seek To Block China’s Access To Nvidia’s H200 AI Chips With New Bill: Report ↗
Via Stocktwits
Topics Artificial Intelligence
Dick’s Sporting Goods Restructures Foot Locker Business With Some Store Closures, Inventory Cleanup ↗
Via Stocktwits
HD Stock Drops Premarket On Lower Profit Guidance – CEO Says Demand Uptick Did Not Arrive ↗
Via Stocktwits
News headline image
Merck Scores FDA Fast-Track Review For Key Cholesterol And Cancer Drugs With Multibillion-Dollar Potential: Report ↗
While one of the drugs reportedly slated for fast-track review is the cholesterol pill Enlicitide decanoate, the other is its cancer therapy Sacituzumab tirumotecan. 
Via Stocktwits
White House AI Czar Sounds Alarm On Nvidia As China Rejects H200 Chips In Favor Of Local Rivals: Report ↗
Via Stocktwits
Topics Artificial Intelligence
News headline image
Costco Stock Dips After Hours Despite Strong Q1 And Holiday Momentum — Retail Bulls Eye Rally Next Week ↗
The company reported adjusted earnings per share of $4.50, above an analyst estimate of $4.27, according to data from Fiscal AI. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
PepsiCo Reportedly Moves To Overhaul North American Supply Chain To Strike Peace With Activist Elliott ↗
As per a report from Bloomberg, the review of the supply chain is among a number of steps the company is taking to reach a settlement with Elliott who built a nearly $4 billion stake in the beverages... 
Via Stocktwits
Topics Economy
General Motors Races To Decouple Supply Chain From China: Report ↗
Via Stocktwits
Topics Economy
Cencora Announces $1B Investment In US ↗
Via Stocktwits
Merck Stock Rises Upon Receipt Of $700M In Funding For Experimental Cancer Drug ↗
Via Stocktwits
Colgate-Palmolive CEO Expects Tepid US Demand But Sees Sequential Gains: ‘Consumer Still Remains Relatively Weak Across North America’ ↗
Via Stocktwits
News headline image
Apple Chip Chief Reportedly Dismisses Concerns About Exit: ‘I Love My Job’ ↗
The clarification from the top executive and architect of the company’s in-house chip efforts come on the heels of a media report last week that Srouji informed CEO Tim Cook that he is considering... 
Via Stocktwits
News headline image
Meta Acquires AI Wearables Startup Limitless AI ↗
The announcement was made by Limitless AI CEO in a video on X. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
PepsiCo Is Close To Striking A Settlement With Activist Giant Elliott After Its $4B Push For Change ↗
Details of the settlement could not be learnt, the Wall Street Journal said. 
Via Stocktwits
News headline image
Nvidia CEO Reportedly Meets Trump To Discuss Export Controls, Shrugs Off Tech Race Fears On Joe Rogan Podcast ↗
Reuters reported on Wednesday, citing a source familiar with the matter, that Huang was in the U.S. capital meeting with lawmakers, where he told them that state-by-state U.S. regulations would slow... 
Via Stocktwits
Topics Artificial Intelligence Government
News headline image
Eli Lilly’s Jaypirca Granted Traditional FDA Approval In Treating Certain Cancers ↗
The agency approved the drug for patients who were previously treated with a covalent BTK inhibitor. 
Via Stocktwits
BMY CEO Expects Cancer Drug Opdivo To Drive Strong Sales In 2025 ↗
Via Stocktwits
News headline image
Instagram Chief Wants Staff To Return To Office Full Time: Report ↗
Business Insider reported on Monday, citing an internal memo, that Mosseri wants Instagram staff to be at the office five days a week. 
Via Stocktwits
News headline image
ORCL Stock Jumps After Analyst Says Market Undervalues Its OpenAI Partnership ↗
Deutsche Bank maintained a ‘Buy’ rating on Oracle and a $375 price target, according to TheFly. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
TJX Stock Rises Pre-Market After Earnings Forecast Hike On Strong Holiday Demand ↗
The company now expects fiscal 2026 earnings per share to be in the range of $4.63 to $4.66, compared with the previous forecast of $4.52 to $4.57. 
Via Stocktwits
News headline image
Microsoft Introduces 'Agent 365' To Track AI Agents Within Systems ↗
Microsoft noted that unmanaged agents can turn into invisible threats that leak data or take unauthorized actions, undermining a company’s security, governance, and compliance framework. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
BMY Stock Slumps 5% After It Scraps Heart Drug Study ↗
The decision follows an analysis by an independent data monitoring committee that the trial is unlikely to meet its key goal. 
Via Stocktwits
News headline image
Gilead’s Experimental One Pill Regimen Proved Non-Inferior To Multi-Pill Regimens In Treating HIV ↗
The company now plans to submit the data from the study to regulatory authorities. 
Via Stocktwits
News headline image
Johnson & Johnson’s Newly Acquired Antipsychotic Drug Approved By FDA For Major Depressive Disorder ↗
JNJ gained access to Caplyta with the $14.6 billion acquisition of Intra-Cellular Therapies, Inc., which closed in April. 
Via Stocktwits
News headline image
Apple Reportedly Developing Budget Mac To Take On Low-Cost Chromebooks, Windows PCs ↗
According to a Bloomberg News report, citing people familiar with the matter, the new low-cost laptop would be developed for students, businesses, and casual users. 
Via Stocktwits
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.